Stock News

Real-time ticker analysis, price-action alerts, and institutional-grade stock data.

5/21, 5:13 PM

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced positive results from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) non-classical mutations (NCMs). These data will be presented by Julia Rotow, M.D., Clinical Director, Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, at the 2026 American Society of Clinical Oncology® (ASCO®) Annual Meeting on Saturday, May 30, 2026, 1:15 PM-2:45 PM CDT.

globenewswire.comView Stock →

5/21, 5:11 PM

IMAX Is Exploring a Sale

The high-end movie screen company's search for a buyer comes as premium theatrical experiences are growing faster than the overall box office.

wsj.comView Stock →

5/21, 5:10 PM

Opinion | You're Probably Overinvested in Bonds

The usual advice is to hold only 60% of your assets in stock. If you're wealthy, a 90/10 split is far better.

wsj.comView Stock →

5/21, 5:10 PM

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

LONDON and GAITHERSBURG, Md., May 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, announces the online publication of an abstract submitted to the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago, Illinois.

globenewswire.comView Stock →

1...26 27 28 29 30

REAL-TIME FEED•TERMINAL PAGE 28